Tang Capital Management’s Eli Lilly LLY Stock Holding History

Tang Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,000	Closed	-$7.63M	–	143
2025 Q3	$7.63M	Hold	10,000	–	–	0.29%	77
2025 Q2	$7.8M	Buy	+10,000	New	+$7.77M	0.39%	64
2024 Q3	–	Sell	-27,000	Closed	-$24.4M	–	160
2024 Q2	$24.4M	Hold	27,000	–	–	2.49%	8
2024 Q1	$21M	Sell	27,000 -3,000	-10%	-$2.14M	2.19%	9
2023 Q4	$17.5M	Hold	30,000	–	–	1.62%	16
2023 Q3	$16.1M	Hold	30,000	–	–	2.27%	11
2023 Q2	$14.1M	Hold	30,000	–	–	2.07%	16
2023 Q1	$10.3M	Buy	30,000 +10,000	+50%	+$3.37M	1.54%	21
2022 Q4	$7.32M	Buy	+20,000	New	+$7.09M	1.06%	27

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Tang Capital Management's LLY Position: Q4 2025 in Review

Tang Capital Management sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 10,000 shares — an estimated $7.63M sold.

Tang Capital Management first reported a position in LLY in Q4 2022 and held it in 9 quarters. The position peaked at $24.4M in Q2 2024. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

Tang Capital Management reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
Tang Capital Management sold 10,000 Eli Lilly shares in Q4 2025, an estimated $7.63M.
Tang Capital Management first reported a position in Eli Lilly in Q4 2022 and held it in 9 quarters.
Tang Capital Management's Eli Lilly position peaked at $24.4M in Q2 2024.
4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Tang Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.